Referred to the House Committee on Energy and Commerce.
This resolution is a nonbinding House statement that supports designating the last Tuesday of April each year as APOL1-Mediated Kidney Disease (AMKD) Awareness Day. It does not create law, change federal programs, or require action by agencies; it simply expresses the House of Representatives view and encourages public awareness. The text urges people, especially those with ancestry from Western or Central Africa, to learn about APOL1-related risks and consider genetic testing and preventive care.
This House resolution expresses support for designating the last Tuesday of April each year as APOL1–Mediated Kidney Disease (AMKD) Awareness Day.
It highlights kidney disease prevalence, racial disparities affecting Black Americans, the role of APOL1 genetic variants, and encourages awareness, research, preventive care, and that people with Western or Central African ancestry consider APOL1 genetic testing.
As a House simple resolution expressing support, it does not create binding law and cannot become statutory law; symbolic passage in the House is likely, not legal enactment.
Relative to its intended legislative type, this bill is a well-structured commemorative resolution: it clearly states the problem and purpose, specifies the day to be recognized, and uses standard 'Whereas' findings to justify the designation. It remains a symbolic expression without binding legal effect.
Liberals want equity, funding, and anti-discrimination safeguards
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals want equity, funding, and anti-discrimination safeguards
Generally supportive of raising awareness about a health disparity that disproportionately affects Black Americans.
Sees potential to promote research, prevention, and equitable care, while wanting safeguards around testing access and discrimination protections.
Supportive of a symbolic resolution raising awareness, but wants clarity on evidence, clinical utility, costs, and protections.
Sees value in promoting research while seeking practical safeguards and measurable outcomes.
Mixed but leans mildly supportive of an awareness day; supports public health awareness but wary about promoting race-targeted genetic testing and government involvement in medical choices.
Prefers private medical decision-making and safeguards against misuse.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House simple resolution expressing support, it does not create binding law and cannot become statutory law; symbolic passage in the House is likely, not legal enactment.
The bill has not accumulated any surfaced votes yet.
Liberals want equity, funding, and anti-discrimination safeguards
As a House simple resolution expressing support, it does not create binding law and cannot become statutory law; symbolic passage in the Ho…
Relative to its intended legislative type, this bill is a well-structured commemorative resolution: it clearly states the problem and purpose, specifies the day to be recognized, and uses standard 'Whereas' findings to…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.